Homa Keshavarz
Papers
1
Total Citations
7
H-Index
1
About
Dr. Homa Keshavarz is a leading clinical researcher in thoracic oncology, with a focused expertise in the surgical management of early-stage non-small cell lung cancer (NSCLC). Her work is particularly centered on optimizing treatment strategies for high-risk patient populations, where standard lobectomy may pose prohibitive risks. Dr. Keshavarz’s most impactful contribution is her 2024 systematic review on sublobar resection for high-risk patients with Stage I NSCLC. This comprehensive analysis synthesized critical evidence to clarify the efficacy and safety of less invasive surgical approaches, directly informing clinical decision-making for a vulnerable group. The study has already garnered 7 citations, underscoring its immediate relevance and influence in shaping surgical guidelines. By rigorously evaluating outcomes such as recurrence and survival, Dr. Keshavarz has advanced the paradigm toward more personalized, risk-adapted care. Her work bridges a crucial gap in thoracic surgery, providing clinicians with the data needed to balance oncologic control with patient quality of life. Dr. Keshavarz’s research continues to drive progress in minimally invasive techniques and evidence-based practice for lung cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1